Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Apotex Research Private Limited
WARNING LETTER
•Apotex Research Private Limited•July 1, 2014

Apotex Research Private Limited – FDA Warning Letter, Jul 1, 2014

Record Details

The FDA issued a Warning Letter to Apotex Research Private Limited (ARPL) following a June 23 - July 1, 2014 inspection, identifying significant CGMP violations, rendering drug products adulterated. The firm's July 22, 2014 response and subsequent correspondence were deemed insufficient.

Violations included: 1. **Incomplete Laboratory Records (21 CFR 211.194(a)):** ARPL performed "trial" testing, disregarded failing results, and reported only passing data. Examples included unreported out-of-specification (OOS) impurity results for (b)(4) and (b)(4) Tablets and selective reporting of HPLC impurity data for (b)(4) mg Tablets. The firm's explanations for retesting were inadequate, and investigations were not extended to all electronic systems. 2. **Inadequate Computer System Controls (21 CFR 211.68(b)):** Unauthorized folders like "WASH" were created on laboratory systems, containing uninvestigated sample injections with OOS results. The firm's focus on intent rather than the seriousness of disregarding failing results and retesting without investigation was noted. 3. **Failure to Prevent Objectionable Microorganisms (21 CFR 211.113(a)):** Missing in-progress microbiological test plates for various products, water, and media growth promotion samples were

Company
Apotex Research Private Limited
Inspection date
July 1, 2014
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Maan Abduldayem (Consumer safety Officer )
  • Parizad Elchidana (Dr.)
  • Thomas J. Cosgrove
View Company Profile

ID · c495a8cb-2d48-4dc3-87b9-48e3e60b41f8

Violation Codes10
21 CFR 21021 CFR 21121 CFR 211.194(a)21 CFR 211.68(b)21 CFR 211.113(a)21 CFR 211.22(d)21 CFR 211.192FD&C Act 501(a)(2)(B)21 U.S.C. 356C(a)(1)FD&C Act 801(a)(3)

Full citation text and observation details available on the Dashboard.

Other documents for Apotex Research Private Limited
  • 483 - 2024-03-15March 15, 2024
  • 483 - 2017-11-17November 17, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Apotex Research Private Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.